New Key Statistics Module, Z-Score and F-Score
OTCPK:CRPGF Key Ratios
Market Cap $ M | 4,602.14 |
Enterprise Value $ M | 5,023.28 |
P/E(ttm) | 8.88 |
PE Ratio without NRI | 6.87 |
Forward PE Ratio | 9.11 |
Price/Book | 0.74 |
Price/Sales | 0.14 |
Price/Free Cash Flow | 2.74 |
Price/Owner Earnings | 4.76 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 34,217.00 |
EPS (TTM) $ | 0.09 |
Beneish M-Score | -2.68 |
10-y EBITDA Growth Rate % | 4.00 |
5-y EBITDA Growth Rate % | 4.80 |
y-y EBITDA Growth Rate % | 13.00 |
EV-to-EBIT | 3.01 |
EV-to-EBITDA | 2.39 |
PEG | 1.43 |
Shares Outstanding M | 6,282.51 |
Net Margin (%) | 1.58 |
Operating Margin % | 6.08 |
Pre-tax Margin (%) | 4.04 |
Quick Ratio | 1.09 |
Current Ratio | 1.33 |
ROA % (ttm) | 1.61 |
ROE % (ttm) | 8.44 |
ROIC % (ttm) | 9.65 |
Dividend Yield % | -- |
Altman Z-Score | 1.50 |
CRPGF Number of Guru Trades
CRPGF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CRPGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CRPGF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
China Resources Pharmaceutical Group Ltd Insider Transactions
No Available Data
News about OTCPK:CRPGF
Total 0- 1